Skin sensitivity: an emerging signal Skin burning and abnormal touch sensitivity (dysesthesia) appears as a dose-related, reversible signal in two case series and post-market surveillance. Trials did not pre-specify it, and the tirzepatide label does not list it
This type of study is important for several reasons: it tells us how long the peptide remains active in the body, what breakdown products are formed (which could themselves have biological activity or be used as markers in drug testing), and helps explain why AOD9604 needs to be administered in certain ways to remain effective
Angiogenesis and Vascular Signalling Models: Investigating peptide-mediated signalling related to vascular and angiogenic pathways
Jeelani, Roohi, et al
Plan ahead: stopthebop.com/actnow Donate to the cause: stopthebop.com/donate See also: Fighting to save our lifeline of glutathione, B12, and more
B12 injections typically deliver about 1,000 mcg per dose, while oral supplements can range from 50 to 5,000 mcg